| Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer J McLaughlin, G Han, KA Schalper, D Carvajal-Hausdorf, V Pelekanou, ... JAMA Oncology, 2015 | 886 | 2015 |
| Immunological differences between primary and metastatic breast cancer B Szekely, V Bossuyt, X Li, VB Wali, GA Patwardhan, C Frederick, A Silber, ... Annals of Oncology 29 (11), 2232-2239, 2018 | 325 | 2018 |
| Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERα36 and GPR30/GPER1 V Pelekanou, M Kampa, F Kiagiadaki, A Deli, P Theodoropoulos, ... Journal of Leucocyte Biology 99 (2), 333-347, 2016 | 196 | 2016 |
| Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer JA Rehman, G Han, DE Carvajal-Hausdorf, BE Wasserman, V Pelekanou, ... Modern Pathology 30 (3), 340-349, 2017 | 178 | 2017 |
| Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological … VI Alexaki, G Notas, V Pelekanou, M Kampa, M Valkanou, ... The Journal of immunology 183 (9), 5948-5956, 2009 | 131 | 2009 |
| Ki67 Reproducibility using Digital Image Analysis: An Inter-platform and Inter-Operator Study B Acs, V Pelekanou, Y Bai, S Martinez-Morilla, M Toki, S Leung, ... Laboratory Investigation, 2018 | 130 | 2018 |
| B7-H3 expression in NSCLC and its association with B7-H4, PD-L1 and tumor-infiltrating lymphocytes M Altan, V Pelekanou, KA Schalper, M Toki, P Gaule, K Syrigos, ... Clinical Cancer Research 23 (17), 5202-5209, 2017 | 124 | 2017 |
| Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance V Pelekanou, DE Carvajal-Hausdorf, M Altan, B Wasserman, ... Breast Cancer Research 19, 1-11, 2017 | 123 | 2017 |
| Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer ES Reisenbichler, G Han, A Bellizzi, V Bossuyt, J Brock, K Cole, O Fadare, ... Modern pathology 33 (9), 1746-1752, 2020 | 120 | 2020 |
| CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers V Pelekanou, F Villarroel-Espindola, ... Breast Cancer Research 20 (154), 2018 | 105 | 2018 |
| Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas V Pelekanou, M Kampa, M Kafousi, K Darivianaki, E Sanidas, DD Tsiftsis, ... BMC cancer 8, 1-9, 2008 | 99 | 2008 |
| Tumor infiltrating lymphocytes and PD-L1 expression in pre- and post-treatment breast cancers in the SWOG S0800 Phase II neoadjuvant chemotherapy trial V Pelekanou, WE Barlow, Z Nahleh, B Wasserman, YC Lo, ... Molecular Cancer Therapeutics, 2018 | 95 | 2018 |
| Membrane-initiated steroid action in breast and prostate cancer M Kampa, V Pelekanou, E Castanas Steroids 73 (9-10), 953-960, 2008 | 82 | 2008 |
| Immune profiling of pre-and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial X Li, S Warren, V Pelekanou, V Wali, A Cesano, M Liu, P Danaher, ... Journal for immunotherapy of cancer 7, 1-9, 2019 | 70 | 2019 |
| Recent insights into the effect of natural and environmental estrogens on mammary development and carcinogenesis V Pelekanou, G Leclercq International Journal of Developmental Biology 55 (7-8-9), 869-878, 2011 | 67 | 2011 |
| TWEAK affects keratinocyte G2/M growth arrest and induces apoptosis through the translocation of the AIF protein to the nucleus S Sabour Alaoui, V Dessirier, E De Araujo, VI Alexaki, V Pelekanou, ... PLoS One 7 (3), e33609, 2012 | 65 | 2012 |
| Quercetin accumulates in nuclear structures and triggers specific gene expression in epithelial cells G Notas, AP Nifli, M Kampa, V Pelekanou, VI Alexaki, P Theodoropoulos, ... The Journal of nutritional biochemistry 23 (6), 656-666, 2012 | 61 | 2012 |
| APRIL binding to BCMA activates a JNK2–FOXO3–GADD45 pathway and induces a G2/M cell growth arrest in liver cells G Notas, VI Alexaki, M Kampa, V Pelekanou, I Charalampopoulos, ... The Journal of Immunology 189 (10), 4748-4758, 2012 | 58 | 2012 |
| ERα36, a new variant of the ERα is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines V Pelekanou, G Notas, M Kampa, E Tsentelierou, J Radojicic, G Leclercq, ... Steroids 77 (10), 928-934, 2012 | 57 | 2012 |
| TPL2 kinase is a suppressor of lung carcinogenesis K Gkirtzimanaki, KK Gkouskou, U Oleksiewicz, G Nikolaidis, D Vyrla, ... Proceedings of the National Academy of Sciences 110 (16), E1470-E1479, 2013 | 56 | 2013 |
Elias CastanasUniversity of Crete, School of MedicineVerified email at uoc.gr
